SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001485003-20-000059
Filing Date
2020-05-11
Accepted
2020-05-08 18:04:51
Documents
5
Period of Report
2020-05-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A sesnform8-kemascientificad.htm 8-K/A 32139
2 EXHIBIT 99.1 sesnemaclinicalscientifi.htm EX-99.1 9183
3 sesnemaclinicalscientifi001.jpg GRAPHIC 236815
4 sesnemaclinicalscientifi002.jpg GRAPHIC 284894
5 sesnemaclinicalscientifi003.jpg GRAPHIC 84071
  Complete submission text file 0001485003-20-000059.txt   877122
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36296 | Film No.: 20862090
SIC: 2834 Pharmaceutical Preparations